Avacta buys Belgium-based Coris Bioconcept for £7.4m
Life science company Avacta Group announced the acquisition of Coris Bioconcept for initial cash consideration of £7.4m on Thursday.
Source: sharecast.com
Page 2 - Launch Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Launch Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Launch Diagnostics Today - Breaking & Trending Today
Avacta : Preliminary Results for the year ended 31 December 2022
A period of continued significant progress Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to... | April 25, 2023
Source: marketscreener.com
Revenue rises, adjusted EBITDA loss improves for Avacta
Oncology-focussed drugs and diagnostics developer Avacta reported full-year revenue of £9.7m in its preliminary results on Tuesday, up from £2.9m year-on-year.
Source: sharecast.com
Investegate |Avacta Group PLC Announcements | Avacta Group PLC: Issue of Equity and Total Voting Rights
Investegate announcements from Avacta Group PLC, Issue of Equity and Total Voting Rights
Source: investegate.co.uk
Investegate |Avacta Group PLC Announcements | Avacta Group PLC: Issue of Equity and Total Voting Rights
Investegate announcements from Avacta Group PLC, Issue of Equity and Total Voting Rights
Source: investegate.co.uk